Acceleron Pharma (United States)
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Acceleron Pharma (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
41%
Total
Publications
367
Total Open
Publications
150
Total
Citations
16K
Open Access
Percentage
41%
Total
Publications
367
Total Open
Publications
150
Total
Citations
16K
Breakdown
Publisher Open
12%
Both
18%
Other Platform Open
11%
Closed
59%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
27
Hybrid 31%
34
No Guarantees 45%
50
Other Platform Open
Domain 89%
93
Institution 15%
16
Other Internet 12%
13
Public 8%
8
Preprint 2%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 93 |
Europe PMC | Domain | 68 |
DOI | Other Internet | 14 |
Semantic Scholar | Public | 7 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 3 |
California Digital Library - eScholarship | Other Internet | 3 |
University of Florence - Florence Research | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - memSIC | Other Internet | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inria | Institution | 2 |